iRadimed
IRMD
17 hedge funds and large institutions have $9.6M invested in iRadimed in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
12.69% more ownership
Funds ownership: 0% → 12.69% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Broadfin Capital
New York
|
+$3.72M |
| 2 |
Sophrosyne Capital
New York
|
+$3.43M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$1.9M |
| 4 |
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.49M |
| 5 |
GMCM
Gruber & McBaine Capital Management
San Francisco,
California
|
+$675K |
Top Sellers
IRMD Hedge Fund Activity: Q3 2014 in Review
17 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2014, worth a combined $9.6M.
Buyers outnumbered sellers: 17 funds opened new IRMD positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Broadfin Capital, opening a new position worth an estimated $3.72M.
- 17 institutional investors held iRadimed (IRMD) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $9.6M of iRadimed stock for Q3 2014.
- 17 funds opened new iRadimed positions in Q3 2014 and 0 closed out, a net change of +17 holders.
- The largest iRadimed buyer in Q3 2014 was Broadfin Capital, an estimated $3.72M added.
Based on aggregated 13F filings for Q3 2014.